Sellbyville, DE -- (SBWIRE) -- 10/16/2018 -- Ophthalmic Viscosurgical Devices Market size is set to exceed USD 790 million by 2024; according to a new research report by Global Market Insights, Inc.

Demand is primarily generated by growing elderly population associated with high potential for ophthalmic surgeries. Longer life expectancy and growing shift towards an older average age has led to increased incidences of cataract driving the global ophthalmic viscosurgical devices market. OVDs are an integral part of the modern anterior segment surgery. The introduction of different multifocal IOL options that can fill gaps throughout the complete range of vision has strongly improved patient satisfaction and the quality of distance vision.

Most common eye diseases affecting the older age group include advanced age-linked macular degeneration, diabetic retinopathy, cataracts, glaucoma, and blindness or poor vision. Many older people develop macular degeneration as part of the body's natural aging process. Cataract surgery was the highest revenue generating application in 2015 due to high global prevalence. Increasing number of vitreoretinal surgeries among geriatric people will drive procedure demand. Development of a low-cost vitreoretinal surgical system designed for emerging regions will expand vitreoretinal surgery demand.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/1134

Dispersive OVDs market offers advantages of using the viscoelastic soft-shell technique for routine cases, especially for complex procedures, which could result in more than 12% CAGR by 2024. Cohesive ophthalmic viscosurgical devices market will seize close to 40% share by 2024, due to their tendency to stick together and move as a mass, which plays an important role in OVD retention in the anterior chamber during phacoemulsification. Some of the available viscous cohesive OVDs are Provisc, Healon, Amvisc and Amvisc Plus.

Europe ophthalmic viscosurgical devices market, especially across Germany, UK and France will experience notable growth; the region accounted for more than 30% of the 2015 global revenue. Demographic shift is set to lead to an increase in the overall sales of Intraocular Lens (IOLs). Age-related macular degeneration (AMD), glaucoma and diabetic retinopathy are the most common cause of blindness in Europe.

Increasing diabetic retinopathy cases and cataract surgical rates coupled with availability of new drugs and devices will boost the Latin America ophthalmic viscosurgical devices market size. The region is filled with immense potential for growth; with Vision 2020 advocacy, governments are considering cataract surgery as a priority, providing treatment free of cost. Argentina could be a profitable region with significantly high number of surgeries being conducted.

2015 U.S. ophthalmic viscosurgical devices market was valued over USD 125 million and is forecast to rise during the coming years with growing geriatric population base, increasing number of minimally invasive surgeries and favorable government policies.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1134

Japan ophthalmic viscosurgical devices market share has witnessed highest gains in 2015 due to prevalence of diabetic retinopathy, high myopia, optic nerve and retinochoroidal degeneration. Cataract prevalence is one of the major cause of blindness in China which will drive the regional ophthalmic viscosurgical devices market over the forecast period. Pure sodium hyaluronate product is currently widely used in China.

Companies operating in ophthalmic viscosurgical devices market include Alcon, Abbott Medical Optics, Carl Zeiss Meditec, Bausch & Lomb, Rayner, CIMA Technology, Precision Lens, Hyaltech, Maxigen Biotech, etc. Medical device manufacturers that can introduce novel innovative equipment will have huge benefits in the developing regions.

Report Content

Chapter 1. Methodology and Scope
1.1 Research Methodology
1.1.1 Initial data exploration
1.1.2 Statistical model and forecast
1.1.3 Industry insights and validation
1.1.4 Research scope and assumptions
1.2 Data Sources
1.2.1 Primary Sources
1.2.2 Secondary Sources

Chapter 2. Executive Summary
2.1 Ophthalmic viscosurgical devices industry 3600 synopsis, 2012 - 2024
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Application trends
2.1.4 Regional trends

Chapter 3. Ophthalmic Viscosurgical Devices Industry Insights
3.1 Industry segmentation
3.2 Industry size & forecast, 2012 - 2024
3.3 Industry impact forces
3.3.1. Growth drivers
3.3.1.1 Rapidly growing geriatric population
3.3.1.2 Increasing incidence of ophthalmic and ocular conditions
3.3.1.3 Expanding base of diabetic patients
3.3.1.4 Technological innovations in intraocular lenses (IOLs)
3.3.2. Industry pitfalls & challenges
3.3.2.1 Lack of awareness leading to lower diagnosis rate
3.3.2.2 Shortage of trained ophthalmologists
3.4 Growth potential analysis
3.5 Industry ecosystem
3.6 Reimbursement scenario
3.6.1 U.S.
3.6.2 Europe
3.6.3 China
3.7 Company market share analysis, 2015
3.7.1 Strategy dashboard
3.8 Porter's analysis
3.9 PESTEL analysis